Evidence map›Paper›PMID 38868227›Full record

ArticleiMeta2023

MultiPrime: A reliable and efficient tool for targeted next-generation sequencing.

Han Xia, Zhe Zhang, Chen Luo, Kangfei Wei, Xuming Li, Xiyu Mu, Meilin Duan, Chuanlong Zhu, Luyi Jin, Xiaoqing He and 5 more

Abstract read
In one paragraph

Article in iMeta, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed.

  1. Article
  2. Article
  3. Identification and validation of a QTL, QSNS.caas-3D.1, for spikelet number per spike in wheat.TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik · 2026
    Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. The Function ofPlants (Basel, Switzerland) · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Observational
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Han XiaSchool of Automation Science and Engineering, Faculty of Electronic and Information Engineering Xi'an Jiaotong University Xi'an China.
Zhe ZhangDepartment of Mechanical and Aerospace Engineering The Hong Kong University of Science and Technology Hong Kong China.
Chen LuoDepartment of Research and Development Hugobiotech Beijing China.
Kangfei WeiDepartment of Research and Development Hugobiotech Beijing China.
Xuming LiDepartment of Research and Development Hugobiotech Beijing China.ORCID 0000-0002-5049-9706
Xiyu MuDepartment of Research and Development Hugobiotech Beijing China.
Meilin DuanDepartment of Research and Development Hugobiotech Beijing China.
Chuanlong ZhuDepartment of Research and Development Hugobiotech Beijing China.
Luyi JinDepartment of Research and Development Hugobiotech Beijing China.
Xiaoqing HeDepartment of Research and Development Hugobiotech Beijing China.
Lingjie TangDepartment of Research and Development Hugobiotech Beijing China.
Long HuDepartment of Research and Development Hugobiotech Beijing China.
Yuanlin GuanDepartment of Research and Development Hugobiotech Beijing China.
David C C LamDepartment of Mechanical and Aerospace Engineering The Hong Kong University of Science and Technology Hong Kong China.
Junbo YangDepartment of Research and Development Hugobiotech Beijing China.ORCID 0000-0003-2187-5749

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We present multiPrime, a novel tool that automatically designs minimal primer sets for targeted next-generation sequencing, tailored to specific microbiomes or genes. MultiPrime enhances primer coverage by designing primers with mismatch tolerance and ensures both high compatibility and specificity. We evaluated the performance of multiPrime using a data set of 43,016 sequences from eight viruses. Our results demonstrated that multiPrime outperformed conventional tools, and the primer set designed by multiPrime successfully amplified the target amplicons. Furthermore, we expanded the application of multiPrime to 30 types of viruses and validated the work efficacy of multiPrime-designed primers in 80 clinical specimens. The subsequent sequencing outcomes from these primers indicated a sensitivity of 94% and a specificity of 89%.

Indexed as

degenerate primer designminimal primer setmultiplex PCRtargeted next‐generation sequencing

Identifiers

PMID38868227
PMCPMC10989836

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.